Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Understanding epilepsy

27.04.2004


Misconceptions hinder treatment



For nearly three thousand years, people believed that epilepsy had a supernatural cause. But the most dangerous misconception about epilepsy is a modern one, according to epilepsy expert Jerome Engel, Jr., M.D., Ph.D.--many people, including physicians, still believe that epilepsy can’t be treated.

"Epilepsy and epileptic seizures are far more common than people realize," said Dr. Engel, Jonathan Sinay Professor of Neurology and Neurobiology at the David Geffen School of Medicine at UCLA, chief of epilepsy and clinical neurophysiology at the UCLA Center for the Health Sciences and director of the UCLA Seizure Disorder Center, Reed Neurological Research Center, Los Angeles.


Dr. Engel spoke today at an American Medical Association media briefing in partnership with the American Academy of Neurology (AAN) and the American Epilepsy Society at the AAN’s annual meeting in San Francisco.

Epileptic seizures are a sign of brain dysfunction. "A very simple way to explain a seizure might be as overactivity in the brain, often, though not always, the result of an injury," he said. "Epilepsy is the chronic condition that results when these brain disturbances persist. Early diagnosis and treatment are vital, because seizures should be stopped before the patient suffers irreversible damage."

Forty million people worldwide have epilepsy. Five to 10 percent of the U.S. population will have a seizure during their lifetime and of those, 30 percent will develop epilepsy. The burden of this disease, however, can’t be understood simply through the numbers, according to Dr. Engel.

"Uncontrolled epilepsy presents an enormous personal burden," said Dr. Engel. "Seizures happen without warning and are frightening and embarrassing; they can result in accidental injury or even death. Imagine the restrictions this places on an active life. A person with epilepsy can’t drive a car, hold certain jobs, or participate fully in recreational activities."

"This is a disease that strikes the young, often children," Dr. Engel said. "This means years and years of disability, lost years of good quality of life and lost earnings. When these elements are factored in, the impact of epilepsy worldwide is equal to the impact of breast cancer in women and lung cancer in men."

The restrictions on daily activity and years of disability would be bad enough, but they are made worse by the stigma that is still attached to epilepsy. "Even today a surprising number of people believe epilepsy is supernatural, caused by possession," said Dr. Engel. "Many people still believe that epilepsy is a psychiatric disorder or mental retardation. An editorial in the British Medical Journal recently put it well: "The history of epilepsy is 3000 years of ignorance, stigma, and discrimination and 100 years of knowledge, stigma, and discrimination."

The most destructive misperception about epilepsy is that it can’t be effectively treated. "Even physicians often believe that seizures can’t be stopped, leading to treatment delays that can result in preventable, irreversible disability," said Dr. Engel. "Our treatment objectives should be no seizures, no side effects and the earliest possible intervention."

Guidelines can have an enormous impact on treatment by educating physicians and directing research goals. "Last year, the American Academy of Neurology introduced guidelines stating that surgical treatment for temporal lobe epilepsy is effective, but did not answer the question of how quickly it should be considered’," said Dr. Engel. "Their recommendation has resulted in the National Institute of Neurological Disorders and Stroke (NINDS) committing $30 million dollars for the Early Randomized Surgical Epilepsy Trial (ERSET) to address this issue."


Media Advisory: To contact Jerome Engel, Jr., M.D., Ph.D., contact Dan Page at 310-794-0777 or dpage@support.ucla.edu. On the day of the briefing, call the AMA’s Science News Department at 312-464-2410, the AAN Press Room at 415-978-3521 or email kstone@aan.com.

Dan Page | EurekAlert!
Further information:
http://www.ama-assn.org/

More articles from Health and Medicine:

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>